Medical versus surgical management for vesicoureteric reflux: The case for medical management

Journal of the Canadian Urological Association

Volumn 4, Issue 4, 2010, Pages 276-278

  Lorenzo, Armando J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957733671     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.1082     Document Type: Note

References (55)

1. Aaronson IA. Does deflux alter the paradigm for the management of children with vesicoureteral reflux? Curr Urol Rep 2005;6:152-156.
2. Canning DA. Deflux for vesicoureteral reflux: pro--the case for endoscopic correction. Urology 2006;68: 239-241.
3. Cendron M. Endoscopic treatment for vesicoureteral reflux: let's not get carried away! Urology 2006;68:242-243.
4. Cendron M. Antibiotic prophylaxis in the management of vesicoureteral reflux. Adv Urol 2008:825475.
5. Cooper CS. Diagnosis and management of vesicoureteral reflux in children. Nat Rev Urol 2009;6:481-489.
6. Cooper CS, Austin JC. Vesicoureteral reflux: who benefits from surgery? Urol Clin North Am 2004;31:535-541, 10.
7. Dave S, Khoury AE. The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol. Indian J Urol 2007;23:403-413.
8. Elder JS, Shah MB, Batiste LR, et al. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Curr Med Res Opin 2007;23:S15-S20.
9. Escribano Subias J, Fraga Rodriguez G. Conservative versus interventional treatment of primary vesicoureteral reflux in children (article in Spanish). Arch Esp Urol 2008;61:229-235.
10. Faust WC, Pohl HG. Role of prophylaxis in vesicoureteral reflux. Curr Opin Urol 2007;17:252-256.
11. Greenfield SP. Management of vesicoureteral reflux in children. Curr Urol Rep 2001;2:113-121.
12. Herndon CD, DeCambre M, McKenna PH. Changing concepts concerning the management of vesicoureteral reflux. J Urol 2001;166:1439-443.
13. Lorenzo AJ, Khoury AE. Endoscopic treatment of reflux: management pros and cons. Curr Opin Urol 2006;16:299-304.
14. MacNeily AE. Pediatric urinary tract infections: current controversies. Can J Urol 2001;8(Suppl 1):18-23.
15. McLorie GA. Vesicoureteral reflux: where have we been, where are we now, and where are we going? Adv Urol 2008:459630.
16. Puri P. Endoscopic correction of vesicoureteral reflux. Curr Opin Urol 2000;10:593-597.
17. Stenberg A, Hensle TW, Lackgren G. Vesicoureteral reflux: a new treatment algorithm. Curr Urol Rep 2002;3:107-114.
18. Isaacs D, Fitzgerald D. Seven alternatives to evidence based medicine. BMJ 1999;319:1618.
19. Estrada CR Jr, Passerotti CC, Graham DA, et al. Nomograms for predicting annual resolution rate of primary vesicoureteral reflux: results from 2,462 children. J Urol 2009;182:1535-1541.
20. Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008;179:674-679; discussion 679.
21. Pennesi M, Travan L, Peratoner L, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 2008;121:e1489-e1494.
22. Montini G, Rigon L, Zucchetta P, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008;122:1064-1071.
23. Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626-632.
24. Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009;361:1748-1759.
25. Mathews R, Carpenter M, Chesney R, et al. Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study. J Pediatr Urol 2009;5:336-341.
26. Greenfield SP, Chesney RW, Carpenter M, et al. Vesicoureteral reflux: the RIVUR study and the way forward. J Urol 2008;179:405-407.
27. Keren R, Carpenter MA, Hoberman A, et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics 2008;122:S240-S250.
28. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-2241.
29. Rushton HG, Majd M, Jantausch B, et al. Renal scarring following reflux and nonreflux pyelonephritis in children: evaluation with 99mtechnetium-dimercaptosuccinic acid scintigraphy. J Urol 1992;147:1327-1332.
30. Peters CA. Challenging the orthodoxy in vesicoureteral reflux: a perfect storm. J Urol 2008;179:1666-1667.
31. Sedberry-Ross S, Rice DC, Pohl HG, et al. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. J Urol 2008;180(4 Suppl):1605-1609; discussion 1610.
32. Traxel E, DeFoor W, Reddy P, et al. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. J Urol 2009;182(4 Suppl):1708-1712.
33. Chi A, Gupta A, Snodgrass W. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2008;179:1966-1969.
34. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998;160(3 Pt 2):1019-1022.
35. Whittam BM, Thomasch JR, Makari JH, et al. Febrile urinary tract infection after ureteroneocystostomy: a contemporary assessment at a single institution. J Urol 2010;183:688-692.
36. Upadhyay J, Bolduc S, Bagli DJ, et al. Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction. J Urol 2003;169:1842-1846; discussion 1846; author reply 1846.
37. Swerkersson S, Jodal U, Sixt R, et al. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol 2007;178:647-651; discussion 650-1.
38. Jodal U, Smellie JM, Lax H, et al. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol 2006;21:785-792.
39. Olbing H, Smellie JM, Jodal U, et al. New renal scars in children with severe VUR: a 10-year study of randomized treatment. Pediatr Nephrol 2003;18:1128-1131.
40. Smellie JM, Tamminen-Mobius T, Olbing H, et al. Five-year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatr Nephrol 1992;6:223-230.
41. Hodson EM, Wheeler DM, Vimalchandra D, et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev 2007:CD001532.
42. Duckett JW, Walker RD, Weiss R. Surgical results: International Reflux Study in Children--United States branch. J Urol 1992;148(5 Pt 2):1674-1675.
43. Weiss R, Duckett J, Spitzer A. Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. J Urol 1992;148(5 Pt 2):1667-1673.
44. Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 2010;125:1010-1019.
45. Chertin B, Kocherov S. Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances. J Pediatr Urol Epub 2009 Nov 5.
46. Lee EK, Gatti JM, Demarco RT, Murphy JP. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup. J Urol 2009;181:1869-1874; discussion 1874-5.
47. Hensle TW, Hyun G, Grogg AL, et al. Part 2: Examining pediatric vesicoureteral reflux: a real-world evaluation of treatment patterns and outcomes. Curr Med Res Opin 2007;23:S7-S13.
48. Conway PH, Cnaan A, Zaoutis T, et al. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179-186.
49. Allen UD, MacDonald N, Fuite L, et al. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 1999;160:1436-1440.
50. Nelson CP, Copp HL, Lai J, et al. Is availability of endoscopy changing initial management of vesicoureteral reflux? J Urol 2009;182:1152-1157.
51. Al-Sayyad AJ, Pike JG, Leonard MP. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol 2005;174(4 Pt 2):1587-1589; discussion 1589.
52. Alconcher LF, Meneguzzi MB, Buschiazzo R, et al. Could prophylactic antibiotics be stopped in patients with history of vesicoureteral reflux? J Pediatr Urol 2009;5:383-388.
53. Thompson RH, Chen JJ, Pugach J, et al. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol 2001;166:1465-1469.
54. National Institute for Health and Clinical Excellence. UTI in children. http://www.nice.org.uk/nicemedia/pdf/CG54quickrefguide.pdf. Accessed June 23,2010.
55. Craig JC, Irwig LM, Knight JF, et al. Does treatment of vesicoureteric reflux in childhood prevent end-stage renal disease attributable to reflux nephropathy? Pediatrics 2000;105:1236-1241.